Briacell Therapeutics CORP. (BCTXZ) — S-1/A Filings
All S-1/A filings from Briacell Therapeutics CORP.. Browse 3 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (3)
-
BriaCell Amends S-1 for Continuous Offering, Eyes Public Capital
— Jul 10, 2025 Risk: high
BriaCell Therapeutics Corp. filed an S-1/A on July 10, 2025, as Amendment No. 2 to its Form S-1 Registration Statement, indicating a proposed sale of securities -
BriaCell Amends S-1, Signals Continuous Offering Strategy
— Jul 9, 2025 Risk: high
BriaCell Therapeutics Corp. (BCTXZ) filed an S-1/A on July 9, 2025, indicating an amendment to its registration statement for a proposed public sale of securiti -
BriaCell Therapeutics Corp. Files S-1/A Amendment
— Apr 23, 2025 Risk: medium
BriaCell Therapeutics Corp. filed an S-1/A amendment on April 23, 2025, for its registration statement. The company, formerly known as Ansell Capital Corp. unti
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX